D, E., & M, S. (2017). Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: A focus on ribociclib. Dove Medical Press.
Style de citation Chicago (17e éd.)D, Edessa, et Sisay M. Recent Advances of Cyclin-dependent Kinases as Potential Therapeutic Targets in HR+/HER2− Metastatic Breast Cancer: A Focus on Ribociclib. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)D, Edessa, et Sisay M. Recent Advances of Cyclin-dependent Kinases as Potential Therapeutic Targets in HR+/HER2− Metastatic Breast Cancer: A Focus on Ribociclib. Dove Medical Press, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.